{
"info": {
"nct_id": "NCT03618472",
"official_title": "Effect of Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells : a Randomized Double Blind Placebo-controlled Trial",
"inclusion_criteria": "* Women with endometrial cancer who undergoing complete surgical staging and agrees to participate in this study\nHealthy volunteers allowed\nMust be FEMALE",
"exclusion_criteria": "* Women without diabetes type 1 and 2\n* Women who have allergy Biguanide\n* Women who have hypoglycemic medication\n* Women who have GFR <45 ml/min/1.73 m2\n* Women who have evidence of stage 3 or 4 of endometrial cancer",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Women with endometrial cancer who undergoing complete surgical staging and agrees to participate in this study",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "endometrial cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "undergoing complete surgical staging",
"criterion": "surgical staging",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "agrees to participate in this study",
"criterion": "study participation",
"requirements": [
{
"requirement_type": "consent",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Women who have allergy Biguanide",
"criterions": [
{
"exact_snippets": "allergy Biguanide",
"criterion": "allergy to Biguanide",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Women who have hypoglycemic medication",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "female"
}
]
},
{
"exact_snippets": "hypoglycemic medication",
"criterion": "medication type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "hypoglycemic"
}
]
}
]
},
{
"line": "* Women who have GFR <45 ml/min/1.73 m2",
"criterions": [
{
"exact_snippets": "GFR <45 ml/min/1.73 m2",
"criterion": "GFR",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 45,
"unit": "ml/min/1.73 m2"
}
}
]
}
]
},
{
"line": "* Women who have evidence of stage 3 or 4 of endometrial cancer",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "female"
}
]
},
{
"exact_snippets": "evidence of stage 3 or 4",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3,
"unit": "stage"
},
{
"operator": "<=",
"value": 4,
"unit": "stage"
}
]
}
}
]
},
{
"exact_snippets": "endometrial cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Women without diabetes type 1 and 2",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "without diabetes type 1",
"criterion": "diabetes type 1",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "without ... type 2",
"criterion": "diabetes type 2",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"failed_miscellaneous": []
}